Toxicity Due to Chemotherapy Recruiting Phase Trials for Bleomycin (DB00290)

IndicationStatusPhase
DBCOND0053872 (Toxicity Due to Chemotherapy)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03199300Investigating Cardiovascular Adverse Events Related to Cancer Treatment